21 results
8-K
EX-1.1
MIST
Milestone Pharmaceuticals Inc
4 Mar 24
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
9:00am
with, and since May 25, 2018, have been and currently are in compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016 … of Treasury’s Office of Foreign Assets Control (“OFAC”), the United Nations Security Council (“UNSC”), the European Union (“EU”), His Majesty’s Treasury (“HMT
424B5
MIST
Milestone Pharmaceuticals Inc
1 Mar 24
Prospectus supplement for primary offering
4:52pm
of the European Union (Withdrawal) Act of 2018.
United Kingdom. In addition, in the United Kingdom, this document is being distributed only
424B5
MIST
Milestone Pharmaceuticals Inc
28 Feb 24
Prospectus supplement for primary offering
5:21pm
to the United Kingdom, the Prospectus Regulation as it forms part of the United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
8-K
EX-1.1
xdq4dvd aj
26 Oct 20
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
4:04pm
8-K
EX-10.1
w2ptxa1g9mho jv07xab
29 Jul 20
Entry into a Material Definitive Agreement
6:06am
10-K
hjxky
6 Mar 20
Annual report
7:07am
10-Q
504mhxh252 syx4e
19 Jun 19
Quarterly report
4:06pm
424B4
wkksimlnkeljvcle
9 May 19
Prospectus supplement with pricing info
4:54pm
S-1/A
5jqwmgaddj3d
29 Apr 19
IPO registration (amended)
6:17am
S-1
zpnc7geva
12 Apr 19
IPO registration
4:53pm
DRS/A
fnq8yqd5
15 Mar 19
Draft registration statement (amended)
12:00am
DRS/A
41g9l
28 Feb 19
Draft registration statement (amended)
12:00am